Better Therapeutics, Inc.
BTTX
$0.0002
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.60M | 6.20M | 6.07M | 15.74M | 22.31M |
| Total Receivables | 73.00K | 60.00K | 406.00K | 45.00K | 62.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 674.00K | 1.17M | 1.97M | 2.50M | 1.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 165.00K | -- |
| Total Current Assets | 7.35M | 7.42M | 8.44M | 18.45M | 23.49M |
|
|
|||||
| Total Current Assets | 7.35M | 7.42M | 8.44M | 18.45M | 23.49M |
| Net Property, Plant & Equipment | 102.00K | 115.00K | 131.00K | 121.00K | 122.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.79M | 3.58M | 3.75M | 3.89M | 4.12M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 483.00K | 483.00K | 483.00K | 488.00K | 488.00K |
| Total Assets | 10.72M | 11.60M | 12.81M | 22.94M | 28.22M |
|
|
|||||
| Total Accounts Payable | 2.31M | 2.99M | 2.51M | 3.04M | 1.26M |
| Total Accrued Expenses | 4.04M | 5.20M | 5.59M | 5.93M | 4.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.59M | 5.69M | 5.54M | 4.53M | 3.13M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.94M | 13.87M | 13.64M | 13.49M | 9.31M |
|
|
|||||
| Total Current Liabilities | 12.94M | 13.87M | 13.64M | 13.49M | 9.31M |
| Long-Term Debt | 7.72M | 8.52M | 9.00M | 10.35M | 11.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.66M | 22.39M | 22.64M | 23.84M | 20.97M |
|
|
|||||
| Common Stock & APIC | 124.37M | 117.66M | 111.03M | 110.60M | 109.99M |
| Retained Earnings | -134.31M | -128.45M | -120.86M | -111.50M | -102.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.94M | -10.79M | -9.83M | -899.00K | 7.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.94M | -10.79M | -9.83M | -899.00K | 7.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.94M | -10.79M | -9.83M | -899.00K | 7.25M |
|
|
|||||
